COMMUNIQUÉS West-GlobeNewswire

CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty

19/02/2024 - 06:45

CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty Clermont-Ferrand, France, 19 February 2024 (06.45am [...]

CARBIOS fédère les acteurs de la filière textile pour impulser la circularité du secteur en présence de M. Bruno Le Maire, Ministre de l’Economie, des Finances et de la Souveraineté industrielle et numérique

19/02/2024 - 06:45

CARBIOS fédère les acteurs de la filière textile pour impulser la circularité du secteur en présence de M. Bruno Le Maire, Ministre de l’Economie, des Finances et de la Souveraineté industrielle et numérique Clermont- [...]

New report exposes harmful impact of Ford government’s privatization scheme on local public hospitals: Health Coalition

18/02/2024 - 18:35

TORONTO, Feb. 18, 2024 (GLOBE NEWSWIRE) -- As the Ford government counters horror stories about unprecedented emergency department wait times, burgeoning deficits, and an unrelenting staffing crisis, it is running high- [...]

Nordic Naturals Issues Voluntary Recall of Baby's Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3

17/02/2024 - 21:45

WATSONVILLE, Calif., Feb. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals is voluntarily recalling one lot of Nordic Naturals Baby’s Vitamin D3 Liquid, 0.76 fl. oz. (22.5 mL), 400 IU (10mcg) D3. This recall is being [...]

BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS

17/02/2024 - 01:17

CEO, Groovy Singh appointed as a new member of the Company’s Board Founder, Lynn Stockwell, appointed as Chair of the Board of Directors Grants, New Mexico, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation ( [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

16/02/2024 - 23:30

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]

R1 RCM to Present at Upcoming Investor Conferences

16/02/2024 - 23:00

MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today [...]

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

16/02/2024 - 22:30

FRANKLIN, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) announced today that effective February 16, 2024, the Talent and Compensation Committee of [...]

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

16/02/2024 - 22:20

BALA CYNWYD, Pa., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]

Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders

16/02/2024 - 22:15

FORT LAUDERDALE, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the Company”) (NASDAQ: MOTS), today announced that its special meeting of stockholders held on February 16, 2024 (the “Special Meeting [...]

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

16/02/2024 - 22:05

Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities CHASKA, Minn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) [...]

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

16/02/2024 - 21:38

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]

Astra Plastic Surgery welcomes Dr. Pallavi Kumbla

16/02/2024 - 21:25

Acclaimed cosmetic and reconstructive surgeon now practicing at Alpharetta and Cumming locations ATLANTA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Astra Plastic Surgery, an acclaimed North Georgia-based cosmetic and [...]

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma

16/02/2024 - 21:19

AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after anti-PD-1 and targeted therapy AMTAGVI deploys patient-specific immune cells that [...]

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

16/02/2024 - 20:42

Sharps and Roncadelle are Joining Forces to Supply Drug Delivery Systems to the International HealthCare Market Through an Expanded Network of North American 3PL Distribution Partnerships NEW YORK, Feb. 16, 2024 (GLOBE [...]

Astiva Health, Inc. Celebrates Grand Opening of New Activity Center in Los Angeles-Koreatown with Support from Rep. Michelle Steel

16/02/2024 - 17:27

ORANGE, Calif. , Feb. 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- Astiva Health Inc. , a fast-growing Medicare Advantage Prescription Drug (MAPD) health plan dedicated to reshaping personalized and comprehensive healthcare [...]

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

16/02/2024 - 17:24

Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of [...]

Healthcare Integrated Technologies, Inc. Signs Letter of Intent to Acquire Glass 8 Holdings, LLC in its Initial Move Toward Becoming a More Diversified Holding Company

16/02/2024 - 15:53

Knoxville, Tennessee, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, has announced today the signing of a non-binding letter [...]

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

16/02/2024 - 15:30

Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET PORTLAND, Maine, Feb. 16, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]